This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Theragenics(R) Renews Credit Agreement

Theragenics Corporation (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has entered into a Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association. The new three year credit agreement, which is unsecured, replaces the $30 million credit agreement with Wells Fargo that was set to expire on October 31, 2012. Borrowings of $22 million that were outstanding under the old credit agreement have been refinanced under the new $40 million credit agreement. The interest rate on outstanding borrowings under the new credit agreement has been reduced from LIBOR plus 2.25% to LIBOR plus 1.75%. The financial covenants in the new credit agreement are substantially similar to the previous credit agreement.

“Obtaining our new credit agreement is a significant accomplishment,” stated M. Christine Jacobs, Chairman and Chief Executive Officer of Theragenics. “We believe that the increase in the available credit and the lower interest rate, in the current credit environment, is attributable to our strategy, our focus on cash flows and the strength of our balance sheet. With this new credit agreement in place we can continue to focus on our strategy of growth and diversification.”

Under the new amended and restated credit agreement, the $40 million revolving line of credit matures on October 10, 2015, with interest payable at LIBOR plus 1.75%. $22 million in revolving loans are currently outstanding under this revolving line of credit. The new credit agreement is unsecured but provides for a lien to be established on substantially all assets of the Company if certain events of default occur. Provisions of the new credit facility require the Company to maintain a minimum cash and investment balance, as defined in the agreement, of $10 million. The terms also require the maintenance of certain minimum financial covenants, including a minimum fixed charge coverage ratio and a maximum debt to tangible net worth.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs